BNP Paribas Financial Markets
ORKA

BNP Paribas Financial Markets’s Oruka Therapeutics ORKA Stock Holding History

BNP Paribas Financial Markets’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Buy
1,079,015
+1,068,087
+9,774% +$71.2M 0.04% 441
2026
Q1 		$536K Buy
10,928
+5,036
+85% +$175K ﹤0.01% 3545
2025
Q4 		$179K Buy
5,892
+145
+3% +$4.04K ﹤0.01% 4102
2025
Q3 		$111K Buy
5,747
+2,944
+105% +$43.6K ﹤0.01% 4252
2025
Q2 		$31.4K Buy
2,803
+2,306
+464% +$24K ﹤0.01% 4420
2025
Q1 		$5.1K Buy
497
+29
+6% +$362 ﹤0.01% 4852
2024
Q4 		$9.07K Buy
+468
New +$11.4K ﹤0.01% 4856

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BNP Paribas Financial Markets's ORKA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Oruka Therapeutics (ORKA) stake by 9,774% in Q2 2026, buying an estimated $71.2M and bringing the position to 1,079,015 shares worth $103M. The position accounts for 0.04% of the portfolio, ranked #441.

BNP Paribas Financial Markets first reported a position in ORKA in Q4 2024 and has held it in 7 quarters since. 237 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • BNP Paribas Financial Markets held 1,079,015 shares of Oruka Therapeutics worth $103M as of Q2 2026.
  • BNP Paribas Financial Markets bought 1,068,087 Oruka Therapeutics shares in Q2 2026, an estimated $71.2M.
  • Oruka Therapeutics made up 0.04% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #441 holding.
  • BNP Paribas Financial Markets first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 237 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.